Citizens reiterates CRISPR Therapeutics stock rating on Casgevy sales
Citizens reiterates CRISPR Therapeutics stock rating on Casgevy sales
Not thousands of headlines. The few lines that move price. For traders: straight from the source, clear and simple.
Citizens reiterates CRISPR Therapeutics stock rating on Casgevy sales
Earnings call transcript: Devyser Q3 2026 profit improves as stock rises 5.7%
Asda names David Potts as group chief executive
Citizens raises Ethos Technologies stock price target on strong Q3 results
Citizens reiterates Backblaze stock rating on AI demand growth
Apple shares slip amid guidance for tightening margins, slowing services growth
Why is Upwork stock surging today?
Google’s use of press by AI chatbot may infringe copyright rules, EU court adviser says
Nordax Bank reports Q3 profit above expectations
Truecaller shares fall 16% on Q3 loss, user growth warning.
Why is Centrica stock rallying today?
Burckhardt Compression posts stronger than expected H1 orders
Why is Eurocash stock surging today?
Why is Palantir Technologies stock sliding today?
Partners like Tether, Circle, and Chainalysis helped freeze $11M of the stolen assets.
Fresenius Medical Care cuts outlook despite Q3 beat
Why is Coloplast stock declining today?
Why is Zalando stock sliding today?
The Guppy Multiple Moving Average bands signal a bearish momentum, even as seasonality and post-midterm history lean bullish.
Mizuho reiterates Outperform on Syndax stock, $43 target
News text belongs to its source; only the headline and a short summary appear here.